AZD-8055 Withdrawn Phase 1 Trials for Malignancies / Advanced Solid Tumours / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01194193Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours